{"id":12129,"date":"2026-09-30T10:20:29","date_gmt":"2026-09-30T14:20:29","guid":{"rendered":"https:\/\/redleafpeptides.com\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/"},"modified":"2026-09-30T10:20:29","modified_gmt":"2026-09-30T14:20:29","slug":"bpc-157-tb-500-20-mg-tache-103190","status":"publish","type":"rlrl_coa","link":"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/","title":{"rendered":"BPC-157 \/ TB-500 20 mg \u2014 T\u00e2che 103190"},"content":{"rendered":"<p>Le plus ancien des deux rapports d'analyse du m\u00e9lange BPC-157 \/ TB-500 de 20 mg. Le flacon a \u00e9t\u00e9 soumis en janvier 2026 sous le nom d'\u00e9chantillon \u00ab Project X 20mg (BPC\/TB combo) \u00bb, re\u00e7u par Janoshik le 27 janvier et analys\u00e9 le 29 janvier. Le laboratoire a indiqu\u00e9 une teneur de 10,56 mg de BPC-157 et de 10,79 mg de TB-500 (TB4).<\/p>\n<p>La demande portait sur une \u00e9valuation g\u00e9n\u00e9rale d'un flacon de peptide, l'approche habituelle pour les soumissions de cette p\u00e9riode, et le certificat indique Peptide Factory Canada, la marque s\u0153ur de Red Leaf, comme client ayant soumis l'\u00e9chantillon. Comme l'analyse de septembre 2026, il ne rapporte que des quantit\u00e9s, sans valeur de puret\u00e9. Il reste publi\u00e9 dans l'historique des rapports plut\u00f4t que d'\u00eatre remplac\u00e9.<\/p>","protected":false},"excerpt":{"rendered":"<p>The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &#8220;Project X 20mg (BPC\/TB combo)&#8221;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-12129","rlrl_coa","type-rlrl_coa","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &quot;Project X 20mg (BPC\/TB combo)&quot;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It\" \/>\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1, index, follow\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_CA\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Red Leaf Research Labs | Canada\u2019s Leading Supplier of Tested Peptides\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"BPC-157 \/ TB-500 20 mg \u2014 Task 103190 | Red Leaf Research Labs\" \/>\n\t\t<meta property=\"og:description\" content=\"The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &quot;Project X 20mg (BPC\/TB combo)&quot;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-30T14:20:29+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-30T14:20:29+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"BPC-157 \/ TB-500 20 mg \u2014 Task 103190 | Red Leaf Research Labs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &quot;Project X 20mg (BPC\/TB combo)&quot;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp\" \/>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>BPC-157 \/ TB-500 20 mg \u2014 Task 103190 | Red Leaf Research Labs<\/title>\n\n","aioseo_head_json":{"title":"BPC-157 \/ TB-500 20 mg \u2014 T\u00e2che 103190 | Red Leaf Research Labs","description":"Le plus ancien des deux rapports d'analyse du m\u00e9lange BPC-157 \/ TB-500 de 20 mg, analys\u00e9 par Janoshik le 29 janvier 2026. Le laboratoire a indiqu\u00e9 une teneur de 10,56 mg de BPC-157 et de 10,79 mg de TB-500 (TB4).","canonical_url":"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1, index, follow","keywords":"","webmasterTools":{"miscellaneous":""},"schema":null,"og:locale":"fr_CA","og:site_name":"Red Leaf Research Labs | Canada\u2019s Leading Supplier of Tested Peptides","og:type":"article","og:title":"BPC-157 \/ TB-500 20 mg \u2014 Task 103190 | Red Leaf Research Labs","og:description":"The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &quot;Project X 20mg (BPC\/TB combo)&quot;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It","og:url":"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/","og:image":"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp","og:image:secure_url":"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp","og:image:width":500,"og:image:height":500,"article:published_time":"2026-09-30T14:20:29+00:00","article:modified_time":"2026-09-30T14:20:29+00:00","twitter:card":"summary_large_image","twitter:title":"BPC-157 \/ TB-500 20 mg \u2014 Task 103190 | Red Leaf Research Labs","twitter:description":"The earlier of two analytical records for the 20 mg BPC-157 \/ TB-500 blend. The vial was submitted in January 2026 under the sample name &quot;Project X 20mg (BPC\/TB combo)&quot;, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4). It","twitter:image":"https:\/\/redleafpeptides.com\/wp-content\/uploads\/2026\/04\/Red-Leaf-Peptides.webp"},"aioseo_meta_data":{"post_id":"12129","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-09-30 14:20:30","updated":"2026-09-30 15:07:15","seo_analyzer_scan_date":"2026-09-30 14:21:04","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"reviewed_by":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/redleafpeptides.com\/fr\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tBPC-157 \/ TB-500 20 mg \u2014 Task 103190\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/redleafpeptides.com\/fr\/"},{"label":"BPC-157 \/ TB-500 20 mg \u2014 Task 103190","link":"https:\/\/redleafpeptides.com\/fr\/coa\/reports\/bpc-157-tb-500-20-mg-task-103190\/"}],"acf":[],"_links":{"self":[{"href":"https:\/\/redleafpeptides.com\/fr\/wp-json\/wp\/v2\/rlrl_coa\/12129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/redleafpeptides.com\/fr\/wp-json\/wp\/v2\/rlrl_coa"}],"about":[{"href":"https:\/\/redleafpeptides.com\/fr\/wp-json\/wp\/v2\/types\/rlrl_coa"}],"version-history":[{"count":0,"href":"https:\/\/redleafpeptides.com\/fr\/wp-json\/wp\/v2\/rlrl_coa\/12129\/revisions"}],"wp:attachment":[{"href":"https:\/\/redleafpeptides.com\/fr\/wp-json\/wp\/v2\/media?parent=12129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}